• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

门静脉栓塞后动力学生长率预测肝切除术后的结果:结直肠癌肝转移和小未来肝残留患者的肝相关死亡率接近零。

Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.

机构信息

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

J Am Coll Surg. 2013 Feb;216(2):201-9. doi: 10.1016/j.jamcollsurg.2012.10.018. Epub 2012 Dec 7.

DOI:10.1016/j.jamcollsurg.2012.10.018
PMID:23219349
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3632508/
Abstract

BACKGROUND

Standardized future liver remnant (sFLR) volume and degree of hypertrophy after portal vein embolization (PVE) have been recognized as important predictors of surgical outcomes after major liver resection. However, the regeneration rate of the FLR after PVE varies among individuals and its clinical significance is unknown.

STUDY DESIGN

Kinetic growth rate (KGR) is defined as the degree of hypertrophy at initial volume assessment divided by number of weeks elapsed after PVE. In 107 consecutive patients who underwent liver resection for colorectal liver metastases with an sFLR volume >20%, the ability of the KGR to predict overall and liver-specific postoperative morbidity and mortality was compared with sFLR volume and degree of hypertrophy.

RESULTS

Using receiver operating characteristic analysis, the best cutoff values for sFLR volume, degree of hypertrophy, and KGR for predicting postoperative hepatic insufficiency were estimated as 29.6%, 7.5%, and 2.0% per week, respectively. Among these, KGR was the most accurate predictor (area under the curve 0.830 [95% CI, 0.736-0.923]; asymptotic significance, 0.002). A KGR of <2% per week vs ≥2% per week correlates with rates of hepatic insufficiency (21.6% vs 0%; p = 0.0001) and liver-related 90-day mortality (8.1% vs 0%; p = 0.04). The predictive value of KGR was not influenced by sFLR volume or the timing of initial volume assessment when evaluated within 8 weeks after PVE.

CONCLUSIONS

Kinetic growth rate is a better predictor of postoperative morbidity and mortality after liver resection for small FLR than conventional measured volume parameters (ie, sFLR volume and degree of hypertrophy).

摘要

背景

标准的未来肝脏残余量(sFLR)体积和门静脉栓塞(PVE)后的肝体积增生程度已被认为是肝切除术后手术结果的重要预测指标。然而,PVE 后 FLR 的再生率在个体之间存在差异,其临床意义尚不清楚。

研究设计

动力学生长率(KGR)定义为初始体积评估时的肝体积增生程度除以 PVE 后经过的周数。在 107 例连续接受 sFLR 体积>20%的结直肠癌肝转移行肝切除术的患者中,将 KGR 预测总体和肝特异性术后发病率和死亡率的能力与 sFLR 体积和增生程度进行比较。

结果

使用受试者工作特征分析,估计预测术后肝衰竭的 sFLR 体积、增生程度和 KGR 的最佳截断值分别为 29.6%、7.5%和 2.0%/周。在这些指标中,KGR 是最准确的预测指标(曲线下面积 0.830[95%CI,0.736-0.923];渐近显著性,0.002)。KGR<2%/周与≥2%/周的肝衰竭发生率(21.6%与 0%;p=0.0001)和与肝脏相关的 90 天死亡率(8.1%与 0%;p=0.04)相关。当在 PVE 后 8 周内评估时,KGR 的预测价值不受 sFLR 体积或初始体积评估时间的影响。

结论

与传统的测量体积参数(即 sFLR 体积和增生程度)相比,动力学生长率是预测小 FLR 肝切除术后发病率和死亡率的更好指标。

相似文献

1
Kinetic growth rate after portal vein embolization predicts posthepatectomy outcomes: toward zero liver-related mortality in patients with colorectal liver metastases and small future liver remnant.门静脉栓塞后动力学生长率预测肝切除术后的结果:结直肠癌肝转移和小未来肝残留患者的肝相关死亡率接近零。
J Am Coll Surg. 2013 Feb;216(2):201-9. doi: 10.1016/j.jamcollsurg.2012.10.018. Epub 2012 Dec 7.
2
Study protocol of the HYPER-LIV01 trial: a multicenter phase II, prospective and randomized study comparing simultaneous portal and hepatic vein embolization to portal vein embolization for hypertrophy of the future liver remnant before major hepatectomy for colo-rectal liver metastases.HYPER-LIV01 试验方案:一项多中心、前瞻性、随机对照研究,比较同时门静脉和肝静脉栓塞与门静脉栓塞在结直肠肝转移行大范围肝切除前对未来肝残留量的肝体积增大的效果。
BMC Cancer. 2020 Jun 19;20(1):574. doi: 10.1186/s12885-020-07065-z.
3
Portal Vein Embolization Reduces Postoperative Hepatic Insufficiency Associated with Postchemotherapy Hepatic Atrophy.门静脉栓塞术可减少化疗后肝萎缩相关的术后肝功能不全。
J Gastrointest Surg. 2018 Jan;22(1):60-67. doi: 10.1007/s11605-017-3467-1. Epub 2017 Jun 5.
4
Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry.301 例连续扩大右半肝切除术:基于系统肝体积测量的结果评估。
Ann Surg. 2009 Oct;250(4):540-8. doi: 10.1097/SLA.0b013e3181b674df.
5
Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO.结直肠癌肝转移患者门静脉阻断后第 1 周肝脏剩余体积增加最大:门静脉阻断后第 1 周结直肠癌肝转移患者肝脏剩余体积增加最大。
J Gastrointest Surg. 2019 Mar;23(3):556-562. doi: 10.1007/s11605-018-4031-3. Epub 2018 Nov 21.
6
Salvage parenchymal liver transection for patients with insufficient volume increase after portal vein occlusion -- an extension of the ALPPS approach.门静脉阻断后肝体积增加不足患者的挽救性肝实质离断术——ALPPS 方法的延伸。
Eur J Surg Oncol. 2013 Nov;39(11):1230-5. doi: 10.1016/j.ejso.2013.08.009. Epub 2013 Aug 29.
7
Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome.肝大部切除术前门静脉栓塞及其对肝脏再生、可切除性和预后的影响。
Br J Surg. 2007 Nov;94(11):1386-94. doi: 10.1002/bjs.5836.
8
Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.门静脉栓塞后残余生长率是预测肝切除术后肝功能衰竭的良好早期指标。
J Am Coll Surg. 2014 Oct;219(4):620-30. doi: 10.1016/j.jamcollsurg.2014.04.022. Epub 2014 Jun 25.
9
Portal vein ligation as an efficient method of increasing the future liver remnant volume in the surgical treatment of colorectal metastases.门静脉结扎术作为在结直肠癌肝转移外科治疗中增加未来肝剩余体积的一种有效方法。
Arch Surg. 2008 Oct;143(10):978-82; discussion 982. doi: 10.1001/archsurg.143.10.978.
10
Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival.门静脉栓塞术可提高广泛性结直肠癌肝转移切除率而不降低生存率。
Br J Surg. 2013 Dec;100(13):1777-83. doi: 10.1002/bjs.9317.

引用本文的文献

1
Right hepatectomy with preservation of segment VI: Seven cases of preliminary experience.保留肝段VI的右肝切除术:7例初步经验
ILIVER. 2022 Apr 15;1(2):122-126. doi: 10.1016/j.iliver.2022.04.003. eCollection 2022 Jun.
2
Augmenting the Future Liver Remnant Prior to Major Hepatectomy: A Review of Options on the Menu.肝大部切除术前增加未来肝残余量:可选方法综述
Ann Surg Oncol. 2025 Jun 8. doi: 10.1245/s10434-025-17607-z.
3
Precision in Liver Surgery: A Comparative Analysis of Volumetry Techniques.肝脏手术的精准性:容积测量技术的比较分析
Ann Surg Oncol. 2025 May 22. doi: 10.1245/s10434-025-17462-y.
4
Combined Portal and Hepatic Vein Embolization Produces Greater Hypertrophy than Portal Vein Embolization Alone with Similar Post-Hepatectomy Outcomes and is not Impacted by Hepatic Artery Infusion Chemotherapy.联合门静脉和肝静脉栓塞比单纯门静脉栓塞产生更大程度的肥大,肝切除术后结果相似,且不受肝动脉灌注化疗的影响。
Ann Surg Oncol. 2025 Apr 30. doi: 10.1245/s10434-025-17287-9.
5
Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trial.结直肠癌肝转移患者门静脉和肝静脉联合栓塞术的安全性与有效性(DRAGON1):一项多中心单臂临床试验
Lancet Reg Health Eur. 2025 Apr 10;53:101284. doi: 10.1016/j.lanepe.2025.101284. eCollection 2025 Jun.
6
Spleen volume after stage-I associated liver partition and portal vein ligation for staged hepatectomy predicts future liver remnant.一期肝段划分联合门静脉结扎分期肝切除术后脾脏体积可预测未来肝残余量。
Langenbecks Arch Surg. 2025 Apr 15;410(1):128. doi: 10.1007/s00423-025-03698-5.
7
Future liver remnant hypertrophy and postoperative outcomes: a retrospective comparison between segmental and main right portal vein embolization.未来肝残余体积肥大与术后结局:节段性与主要右门静脉栓塞的回顾性比较
CVIR Endovasc. 2025 Mar 28;8(1):27. doi: 10.1186/s42155-025-00537-y.
8
Negative impact of chemotherapy on kinetic growth rate of the future liver remnant if applied following PVE or ALPPS.如果在门静脉栓塞术(PVE)或联合肝脏分隔和门静脉结扎的二步肝切除术(ALPPS)后进行化疗,其对未来肝残余体积生长动力学速率的负面影响。
PLoS One. 2025 Mar 7;20(3):e0307937. doi: 10.1371/journal.pone.0307937. eCollection 2025.
9
Management of intrahepatic cholangiocarcinoma: a review for clinicians.肝内胆管癌的管理:临床医生综述
Gastroenterol Rep (Oxf). 2025 Jan 26;13:goaf005. doi: 10.1093/gastro/goaf005. eCollection 2025.
10
Prediction of left lobe hypertrophy with voxel-based dosimetry using integrated Y-90 PET/MRI after radioembolization of liver tumors with Y-90 microspheres.使用Y-90微球对肝肿瘤进行放射性栓塞后,利用集成式Y-90 PET/MRI基于体素的剂量测定法预测左叶肥大。
Eur J Nucl Med Mol Imaging. 2025 Apr;52(5):1695-1707. doi: 10.1007/s00259-024-07023-y. Epub 2024 Dec 17.

本文引用的文献

1
High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome.两阶段切除治疗晚期结直肠肝转移的高存活率:基于反应的选择和完全切除定义了结果。
J Clin Oncol. 2011 Mar 10;29(8):1083-90. doi: 10.1200/JCO.2010.32.6132. Epub 2011 Jan 24.
2
Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases.对于结直肠癌肝转移患者,术前延长化疗并不能改善病理反应,反而会增加肝切除术后的肝功能不全发生率。
Ann Surg Oncol. 2010 Nov;17(11):2870-6. doi: 10.1245/s10434-010-1166-1. Epub 2010 Jun 22.
3
Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy?156 例结直肠肝转移同期患者的手术策略:经典、联合还是反转策略?
J Am Coll Surg. 2010 Jun;210(6):934-41. doi: 10.1016/j.jamcollsurg.2010.02.039.
4
Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma.门静脉栓塞术在改善肝细胞癌围手术期结局中的应用和局限性。
Semin Oncol. 2010 Apr;37(2):102-9. doi: 10.1053/j.seminoncol.2010.03.013.
5
Kinetics of liver volume changes in the first year after portal vein embolization.门静脉栓塞术后第一年肝脏体积变化的动力学
Arch Surg. 2010 Apr;145(4):351-4; discussion 354-5. doi: 10.1001/archsurg.2010.42.
6
Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections.双术者法肝实质离断有助于减少肝切除术患者的输血率:1557 例连续肝切除术分析。
Surgery. 2010 Jan;147(1):40-8. doi: 10.1016/j.surg.2009.06.027. Epub 2009 Sep 6.
7
Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry.301 例连续扩大右半肝切除术:基于系统肝体积测量的结果评估。
Ann Surg. 2009 Oct;250(4):540-8. doi: 10.1097/SLA.0b013e3181b674df.
8
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients.结直肠癌肝转移根治性手术后的复发率及模式:一项对1669例患者的国际多机构分析
Ann Surg. 2009 Sep;250(3):440-8. doi: 10.1097/SLA.0b013e3181b4539b.
9
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy.转移性结直肠癌患者生存率的提高与肝切除的采用及化疗的改善有关。
J Clin Oncol. 2009 Aug 1;27(22):3677-83. doi: 10.1200/JCO.2008.20.5278. Epub 2009 May 26.
10
Is embolization of segment 4 portal veins before extended right hepatectomy justified?在扩大右肝切除术前对门静脉4段进行栓塞是否合理?
Surgery. 2008 Nov;144(5):744-51. doi: 10.1016/j.surg.2008.05.015. Epub 2008 Aug 10.